Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440
Published December 22, 2021 · Recall initiated: October 11, 2021
Summary
FDA records medical device Class II recall Z-0382-2022, published December 22, 2021 and initiated October 11, 2021. Recalling firm: Clark Laboratories, Inc.; Status: Terminated; Reported quantity: 53 units; Lot: Lot # 056 Expiration Date: 2022-11-28 UDI: 05391516744065. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Contamination of the conjugate may cause a pipetting issue which then could lead to an invalid assay
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Clark Laboratories, Inc.
- Distributor
- OH, UT
- Lot
- Lot # 056 Expiration Date: 2022-11-28 UDI: 05391516744065
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAHand Sanitizer Foam (ethyl alcohol), 62% v/v, packaged in a) 1.5 Oz. cans, NDC 53329-970-12; b) 8 Oz. (227 g)December 29, 2021
- FDAMoxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, LeitersDecember 29, 2021
- FDAEVIS EXERA II DUODENOVIDEOSCOPE OLYMPUS TJF-Q180V Model Number: TJF-Q180VDecember 22, 2021
- FDABox Label: activ5 TINY GYM IN YOUR POCKET activbody Model: Activ5 User Manual: ACTIV5 USER MANUAL Welcome toDecember 22, 2021
- FDARoyalSilk Non-Reinforced Surgical Gowns X-large SKU: 9548December 22, 2021
- FDAVenous Access Pack-LF Convenience KitDecember 22, 2021
Questions about this recall
Was Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440 recalled?
Yes. FDA published recall Z-0382-2022 on December 22, 2021. Reported hazard: Contamination of the conjugate may cause a pipetting issue which then could lead to an invalid assay
What should I do if I have this product?
Voluntary: Firm initiated · Letter